Price T Rowe Associates Inc Enovis Corp Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Enovis Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 371,148 shares of ENOV stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
371,148
Previous 381,118
2.62%
Holding current value
$16.2 Million
Previous $23.8 Million
29.51%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ENOV
# of Institutions
305Shares Held
60.3MCall Options Held
1.63MPut Options Held
411K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$290 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$237 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$233 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.15MShares$138 Million0.04% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH2.79MShares$122 Million0.55% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.36B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...